✦ LIBER ✦

Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents

✍ Scribed by Shahidi, M.; Tay, E. S. E.; Read, S. A.; Ramezani-Moghadam, M.; Chayama, K.; George, J.; Douglas, M. W.

Book ID: 127312713
Publisher: Society for General Microbiology
Year: 2014
Tongue: English
Weight: 498 KB
Volume: 95
Category: Article
ISSN: 0022-1317
DOI: 10.1099/vir.0.067231-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triglyceride synthesis and hepatitis C v

Triglyceride synthesis and hepatitis C virus production: Identification of a novel host factor as antiviral target

✍ Catherine Schuster; Mathieu Lefèvre; Thomas F. Baumert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Hepatitis C virus (HCV) infection is closely tied to the lipid metabolism of liver cells. Here we identify the triglyceride-synthesizing enzyme diacylglycerol acyltransferase-1 (DGAT1) as a key host factor for HCV infection. DGAT1 interacts with the viral nucleocapsid core and is required for the tr